QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Inclusion Criteria: * Aged ≥18 years. * Fasting low density lipoprotein cholesterol (LDL-C) ≥2.6 mmol/L and \<4.9 mmol/L at screening. * Atherosclerotic cardiovascular disease (ASCVD) risk stratification as low or intermediate risk per Chinese guidelines. * Not currently on lipid-lowering therapy. * estimated Glomerular Filtration Rate (eGFR) \>30 mL/min/1.73 m². * Willing to provide informed consent. Exclusion Criteria: * History of AAtherosclerotic cardiovascular disease (ASCVD)(e.g., myocardial infarction, stroke). * Familial hypercholesterolemia. * Uncontrolled hypertension (Systolic Blood Pressure ≥160 mmHg or (Diastolic Blood Pressure ≥100 mmHg). * Poorly controlled type 2 diabetes (Glycated Haemoglobin A1c \>8.0%). * Use of prohibited lipid-lowering drugs within specified washout periods. * Significant liver or kidney disease. * Pregnancy or lactation. * Other conditions deemed unsuitable by investigator.